21st Jun 2018 10:25
LONDON (Alliance News) - Anti-microbial resistance-focused biotechnology developer Destiny Pharma PLC said Thursday it has appointed Nick Rodgers as an independent non-executive director with immediate effect.
Rodgers is currently chairman of South East Health Technologies Alliance, a non-profit UK health technology networking organisation.
Destiny Pharma shares were untraded at 109.90 pence each.
Related Shares:
DEST.L